pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Sep 24·1 min read
save

Heidi Overton, a New Mexico-born physician, nominated as FDA commissioner

Sep 24, 2026·read at STAT ↗RegulatoryPositive

Heidi Overton grew up in Gallup, New Mexico, and as a college freshman expressed a desire to become a doctor and return to her small hometown. Her early ambition was highlighted in a 2007 interview where she said she would love to practice medicine in Gallup.

She entered the University of New Mexico School of Medicine through an early‑application program and earned her medical degree while maintaining ties to her rural roots. Overton’s career has been marked by a calm, reasoned approach that kept her out of the spotlight but earned her respect within federal health agencies.

Over the past two decades she rose through the ranks of the Food and Drug Administration, taking on increasingly senior roles that culminated in her selection as the youngest‑ever nominee to lead the agency. President Trump announced her nomination, citing her medical background and experience in regulatory affairs.

If confirmed, Overton would become the first FDA commissioner from a rural background, bringing a perspective shaped by both clinical practice and federal oversight to the nation’s drug and device regulator.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: How a young doctor rose from rural New Mexico to FDA commissioner nominee”

read at STAT ↗
458 words · retrieved Sep 24
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 13h agoSTAT+: What are the health stakes of the midterms? Policymakers, lobbyists, and experts weigh inSTAT
  • 1d agoSTAT+: Up and down the ladder: The latest comings and goingsSTAT
  • 1d agoHow Election Day can affect your heartSTAT
  • 1d agoAssessing Merck and Moderna’s mRNA cancer vaccineSTAT
  • 1d agoSTAT+: Pharmalittle: We’re reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and moreSTAT